Locations across Queensland within Queensland Cardiovascular Group

Phone (07) 3016 1111

Dr Michael Adsett

MBBS | FRACP

Education and
Training

Fellow of the St Andrew’s Heart Institute in Cardiac Electrophysiology
St Andrew’s Heart Institute | Brisbane, Australia

Fellow of the Royal Australian College of Physicians (FRACP)
Royal Australasian College of Physicians | Australia

Bachelor of Medicine, Bachelor of Surgery (MBBS)
Bachelor of Science
University of Queensland | Brisbane, Australia

Procedures and Conditions​

cardioversion treatment icon
Cardioversion
radiofrequency ablation
Radiofrequency Ablation
cryoablation
Cryoablation
implantable cardioverter defibrillator
Defibrillators
pacemakers icon
Pacemakers
cardiac resynchronisation therapy
Cardiac Resynchronisation Devices

About Dr Adsett

Dr Michael Adsett is a Director of the Queensland Cardiovascular Group and specialises in cardiac electrophysiology.

His clinical interests include cardiac electrophysiology, radiofrequency ablation, pacemaker implantation, including biventricular pacemaker implantation, automatic implantable defibrillators and is an expert in general arrhythmia management.

Dr Adsett was awarded first class honours as a graduate of the University of Queensland in Medicine, and holds a Fellowship of the Royal Australasian College of Physicians in cardiology.

After obtaining his postgraduate qualifications, Dr Adsett undertook advanced training at the St Andrew’s Heart Institute, training in cardiac electrophysiology procedures under the supervision of Dr Wayne Stafford and Dr John Hayes.

Dr Adsett’s research and training interests include demonstration and training in cardiac device implantation.

Professional Memberships
and Awards

St Andrew’s Medical Institute
Member 2005

St Andrew’s Heart Institute
Fellow

Royal Australian College of Physicians (FRACP)
Fellow

surgery

Research and Publications​

  1. (Dec 1997). Serum and blister fluid cytokines and complement proteins in a patient with Henoch Schonlein purpura associated with a bullous skin rash
  2. (Sep 2000). Use of echocardiographic assessment of myocardial viability to guide management of patients with ischemic heart disease.
  1. (June 2003). Eosinophilic Heart: Marked Left Ventricular Wall Thickening and Myocardial Dysfunction Improving With Corticosteroid Therapy.
  2. (Dec 2007). Radiation Exposure in Electrophysiology (EP) and Device Implant Procedures
  3. (Feb 2008). Medicinal mishap: Cabergoline-induced valvulopathy
  1. (Dec 2012). Monitoring Procedural Outcomes in Cardiac Electrophysiology
  2. (Dec 2013). Radiation Risk Reduction in Cardiac Electrophysiology Through Use of a Gridless Imaging Technique
  3. (Nov 2020). 262 The Impact of Technology and Technique Changes on Radiation Risk in Cardiac Electrophysiology
  4. Adsett M, Hayes J, Stafford W, Perel R, Denman R, Dauber K, Gould P, Rivers J, Smith I. (2020) 29 (2) S118. The Impact of Technology and Technique Change on Radiation Risk in Cardiac Electrophysiology. Heart, Lung and Circulation
  5. Haqqani H, Denman R, Chan N, Yuen Ho, Gavin A, Adsett M, Mok N, Lee V, Tao C, Hayes J. (APHRS 2021, November 2021). Early Experience with a Novel 3D mapping system with two imaging modalities.